Systemic antioxidant properties of L-carnitine in two different models of arterial hypertension

Journal of Physiology and Biochemistry

Volumn 66, Issue 2, 2010, Pages 127-136

  Mate, Alfonso ^a   Miguel Carrasco, José L ^a   Monserrat, María T ^b   Vázquez, Carmen M ^a  

^a UNIVERSITY OF SEVILLE   (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN MACARENA   (Spain)

Author keywords

Captopril; L carnitine; L NAME; Nitric oxide; Oxidative stress; Spontaneously hypertensive rats

Indexed keywords

CAPTOPRIL; CARNITINE; GLUTATHIONE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ENZYME ACTIVITY; EXPERIMENTAL MODEL; HYPERTENSION; NONHUMAN; OXIDATIVE STRESS; RAT; SYSTOLIC BLOOD PRESSURE;

ANIMALS; ANTIHYPERTENSIVE AGENTS; ANTIOXIDANTS; BLOOD PRESSURE; CAPTOPRIL; CARNITINE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; HYPERTENSION; MALE; NG-NITROARGININE METHYL ESTER; NITRATES; NITRITES; RATS; RATS, INBRED SHR; RATS, INBRED WKY;

ANIMALIA; RATTUS;

EID: 77955093804     PISSN: 11387548     EISSN: 18778755     Source Type: Journal    
DOI: 10.1007/s13105-010-0017-7     Document Type: Article

References (50)

1. Arthur JR, Boyne R (1985) Superoxide dismutase and glutathione peroxidase activities in neutrophils from selenium deficient and copper deficient cattle. Life Sci 36:1569-1575.
2. Berry C, Brosnan MJ, Fennell J, Hamilton CA, Dominiczak AF (2001) Oxidative stress and vascular damage in hypertension. Curr Opin Nephrol Hypertens 10:247-255.
3. Bolterman RJ, Manriquez MC, Ortiz Ruiz MC, Juncos LA, Romero JC (2005) Effects of captopril on the renin angiotensin system, oxidative stress, and endothelin in normal and hypertensive rats. Hypertension 46:943-947.
4. Bravo Y, Quiroz Y, Ferrebuz A, Vaziri ND, Rodriguez-Iturbe B (2007) Mycophenolate mofetil administration reduces renal inflammation, oxidative stress, and arterial pressure in rats with lead-induced hypertension. Am J Physiol Ren Physiol 293:F616-F623.
5. Cao G, Prior RL (1999) Measurement of oxygen radical absorbance capacity in biological samples. Meth Enzymol 299:50-62.
6. Carlberg I, Mannervik B (1975) Purification and characterization of the flavoenzyme glutathione reductase from rat liver. J Biol Chem 250:5475-5480.
7. Cediel E, Sanz-Rosa D, Oubina MP, Heras N de las, Gonzalez Pacheco FR, Vegazo O, Jimenez J, Cachofeiro V, Lahera V (2003) Effect of AT1 receptor blockade on hepatic redox status in SHR: possible relevance for endothelial function? Am J Physiol Regul Integr Comp Physiol 285:R674-R681.
8. Dayanandan A, Kumar P, Panneerselvam C (2001) Protective role of L-carnitine on liver and heart lipid peroxidation in atherosclerotic rats. J Nutr Biochem 12:254-257.
9. de Cavanagh EM, Inserra F, Ferder L, Fraga CG (2000) Enalapril and captopril enhance glutathione-dependent antioxidant defenses in mouse tissues. Am J Physiol Regul Integr Comp Physiol 278:R572-R577.
10. Dincer Y, Sekercioglu N, Pekpak M, Gunes KN, Akcay T (2008) Assessment of DNA oxidation and antioxidant activity in hypertensive patients with chronic kidney disease. Ren Fail 30:1006-1011.
11. Duarte J, Jimenez R, O'Valle F, Galisteo M, Perez-Palencia R, Vargas F, Perez-Vizcaino F, Zarzuelo A, Tamargo J (2002) Protective effects of the flavonoid quercetin in chronic nitric oxide deficient rats. J Hypertens 20:1843-1854.
12. Famularo G, De SC, Trinchieri V, Mosca L (2004) Carnitines and its congeners: a metabolic pathway to the regulation of immune response and inflammation. Ann N Y Acad Sci 1033:132-138.
13. Ferrari R, Merli E, Cicchitelli G, Mele D, Fucili A, Ceconi C (2004) Therapeutic effects of L-carnitine and propionyl-L-carnitine on cardiovascular diseases: a review. Ann N Y Acad Sci 1033:79-91.
14. Gomez-Amores L, Mate A, Miguel-Carrasco JL, Jimenez L, Jos A, Camean AM, Revilla E, Santa-Maria C, Vazquez CM (2007) L-carnitine attenuates oxidative stress in hypertensive rats. J Nutr Biochem 18:533-540.
15. Gomez-Amores L, Mate A, Revilla E, Santa-Maria C, Vazquez CM (2006) Antioxidant activity of propionyl-Lcarnitine in liver and heart of spontaneously hypertensive rats. Life Sci 78:1945-1952.
16. Gonzalez W, Fontaine V, Pueyo ME, Laquay N, Messika-Zeitoun D, PhilippeM, Arnal JF, Jacob MP, Michel JB (2000) Molecular plasticity of vascular wall during N(G)-nitro-Larginine methyl ester-induced hypertension: modulation of proinflammatory signals. Hypertension 36:103-109.
17. Hamilton CA (2004) Strategies to reduce oxidative stress in cardiovascular disease. Clin Sci (Lond) 106:219-234.
18. Irat AM, Aktan F, Ozansoy G (2003) Effects of L-carnitine treatment on oxidant/antioxidant state and vascular reactivity of streptozotocin-diabetic rat aorta. J Pharm Pharmacol 55:1389-1395.
19. Ito H, Torii M, Suzuki T (1992) A comparative study on defense systems for lipid peroxidation by free radicals in spontaneously hypertensive and normotensive rat myocardium. Comp Biochem Physiol B 103:37-40.
20. Izgut-Uysal VN, Agac A, Derin N (2003) Effect of Lcarnitine on carrageenan-induced inflammation in aged rats. Gerontology 49:287-292.
21. Kalaiselvi T, Panneerselvam C (1998) Effect of L-carnitine on the status of lipid peroxidation and antioxidants in aging rats. J Nutr Biochem 9:575-581.
22. Kataoka C, Egashira K, Ishibashi M, Inoue S, Ni W, Hiasa K, Kitamoto S, Usui M, Takeshita A (2004) Novel antiinflammatory actions of amlodipine in a rat model of arteriosclerosis induced by long-term inhibition of nitric oxide synthesis. Am J Physiol Heart Circ Physiol 286: H768-H774.
23. Kitamoto S, Egashira K, Kataoka C, Usui M, Koyanagi M, Takemoto M, Takeshita A (2000) Chronic inhibition of nitric oxide synthesis in rats increases aortic superoxide anion production via the action of angiotensin II. J Hypertens 18:1795-1800.
24. Landmesser U, Dikalov S, Price SR, McCann L, Fukai T, Holland SM, Mitch WE, Harrison DG (2003) Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension. J Clin Invest 111:1201-1209.
25. Lassegue B, Griendling KK (2004) Reactive oxygen species in hypertension; an update. Am J Hypertens 17:852-860.
26. Llorens S, Salazar FJ, Nava E (2005) Assessment of the nitric oxide system in the heart, aorta and kidney of aged Wistar-Kyoto and spontaneously hypertensive rats. J Hypertens 23:1507-1514.
27. Mancia G et al (2007) 2007 Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European society of hypertension (ESH) and of the european society of cardiology (ESC). J Hypertens 25:1105-1187. (Pubitemid 46924065)
28. Marzinzig M, Nussler AK, Stadler J, Marzinzig E, Barthlen W, Nussler NC, Beger HG, Morris SM Jr, Bruckner UB Improved methods to measure end products of nitric oxide in biological fluids: nitrite, nitrate, and Snitrosothiols. Nitric Oxide 1:177-189.
29. Miguel-Carrasco JL, Mate A, Monserrat MT, Arias JL, Aramburu O, Vazquez CM (2008) The role of inflammatory markers in the cardioprotective effect of L-carnitine in L-NAME-induced hypertension. Am J Hypertens 21: 1231-1237.
30. Paglia DE, Valentine WN (1967) Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 70:158-169.
31. Paravicini TM (2008) NADPH oxidases, reactive oxygen species, and hypertension: clinical implications and therapeutic possibilities. Diab Care 31(Suppl 2):S170-S180.
32. Pauly DF, Pepine CJ (2003) The role of carnitine in myocardial dysfunction. Am J Kidney Dis 41:S35-S43.
33. Rajasekar P, Palanisamy N, Anuradha CV (2007) Increase in nitric oxide and reductions in blood pressure, protein kinase C beta II and oxidative stress by L-carnitine: a study in the fructose-fed hypertensive rat. Clin Exp Hypertens 29:517-530.
34. Rauchova H, Dobesova Z, Drahota Z, Zicha J, Kunes J (1998) The effect of chronic L-carnitine treatment on blood pressure and plasma lipids in spontaneously hypertensive rats. Eur J Pharmacol 342:235-239.
35. Redon J, Oliva MR, Tormos C, Giner V, Chaves J, Iradi A, Saez GT (2003) Antioxidant activities and oxidative stress byproducts in human hypertension. Hypertension 41:1096- 1101.
36. Rodriguez-Iturbe B, Zhan CD, Quiroz Y, Sindhu RK, Vaziri ND (2003) Antioxidant-rich diet relieves hypertension and reduces renal immune infiltration in spontaneously hypertensive rats. Hypertension 41:341-346. (Pubitemid 36204912)
37. Samiec PS (1998) Glutathione in human plasma: decline in association with aging, age-related macular degeneration, and diabetes. Free Radic Biol Med 24:699-704.
38. Sayed-Ahmed MM, Khattab MM, Gad MZ, Mostafa N (2001) L-carnitine prevents the progression of atherosclerotic lesions in hypercholesterolaemic rabbits. Pharmacol Res 44:235-242.
39. Sener G, Paskaloglu K, Satiroglu H, Alican I, Kacmaz A, Sakarcan A (2004) L-carnitine ameliorates oxidative damage due to chronic renal failure in rats. J Cardiovasc Pharmacol 43:698-705. (Pubitemid 38534071)
40. Simko F, Pechanova O, Pelouch V, Krajcirovicova K, Mullerova M, Bednarova K, Adamcova M, Paulis L (2009) Effect of melatonin, captopril, spironolactone and simvastatin on blood pressure and left ventricular remodelling in spontaneously hypertensive rats. J Hypertens 27(Suppl 6): S5-10-S5-10.
41. Takemoto M, Egashira K, Usui M, Numaguchi K, Tomita H, Tsutsui H, Shimokawa H, Sueishi K, Takeshita A (1997) Important role of tissue angiotensin-converting enzyme activity in the pathogenesis of coronary vascular and myocardial structural changes induced by long-term blockade of nitric oxide synthesis in rats. J Clin Invest 99:278-287.
42. Torok J (2008) Participation of nitric oxide in different models of experimental hypertension. Physiol Res 57:813-825.
43. Ulker S, McMaster D, McKeown PP, Bayraktutan U (2003) Impaired activities of antioxidant enzymes elicit endothelial dysfunction in spontaneous hypertensive rats despiteenhanced vascular nitric oxide generation. Cardiovasc Res 59:488-500.
44. Vescovo G, Ravara B, Gobbo V, Sandri M, Angelini A, Della BM, Dona M, Peluso G, Calvani M, Mosconi L, Dalla LL (2002) L-Carnitine: a potential treatment for blocking apoptosis and preventing skeletal muscle myopathy in heart failure. Am J Physiol Cell Physiol 283:C802-C810. (Pubitemid 34920313)
45. Vesela E, Racek J, Trefil L, Jankovy'ch V, Pojer M (2001) Effect of L-carnitine supplementation in hemodialysis patients. Nephron 88:218-223.
46. Wilcox CS (2002) Reactive oxygen species: roles in blood pressure and kidney function. Curr Hypertens Rep 4:160-166.
47. Yasunari K, Maeda K, Nakamura M, Yoshikawa J (2002) Oxidative stress in leukocytes is a possible link between blood pressure, blood glucose, and C-reacting protein. Hypertension 39:777-780.
48. Yuan YV, Kitts DD (2002) Dietary fat source and cholesterol interactions alter plasma lipids and tissue susceptibility to oxidation in spontaneously hypertensive (SHR) and normotensive Wistar Kyoto (WKY) rats. Mol Cell Biochem 232:33-47.
49. Yuan YV, Kitts DD, Godin DV (1998) Variations in dietary fat and cholesterol intakes modify antioxidant status of SHR and WKY rats. J Nutr 128:1620-1630.
50. Zhan CD, Sindhu RK, Pang J, Ehdaie A, Vaziri ND (2004) Superoxide dismutase, catalase and glutathione peroxidase in the spontaneously hypertensive rat kidney: effect of antioxidant-rich diet. J Hypertens 22:2025-2033.